Dow Down0.02% Nasdaq Up0.80%

Halozyme Therapeutics, Inc. (HALO)

8.76 Up 0.24(2.82%) 3:33PM EST - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.1
Mean Recommendation (last week):2.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:13.57
Median Target:13.00
High Target:24.00
Low Target:5.00
No. of Brokers:7

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jun 12, 2014UBSUpgradeNeutralBuy
Aug 2, 2013BarclaysDowngradeOverweightEqual Weight
Apr 1, 2011Stifel NicolausInitiated Buy
Oct 19, 2010JMP SecuritiesInitiated Mkt Perform
Oct 6, 2010Barclays CapitalInitiated Overweight
Apr 8, 2010William BlairInitiated Outperform
Mar 22, 2010Brean MurrayUpgradeHoldBuy
Oct 13, 2009Wedbush MorganUpgradeNeutralOutperform
Apr 29, 2009Roth CapitalUpgradeHoldBuy
Apr 21, 2009Wedbush MorganInitiated Buy

More Upgrades & Downgrades for HALO

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0222

Data provided by Thomson/First Call

Currency in USD.